Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy
Keyword(s):
Abstract Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.
2016 ◽
Vol 23
(Suppl 1)
◽
pp. A145.2-A146
2019 ◽
Vol 156
(2)
◽
pp. 446-460.e2
◽